Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients

International Journal of Oncology

Volumn 44, Issue 4, 2014, Pages 1073-1083

  El Saghire, Houssein ^a,b   Vandevoorde, Charlot ^b   Ost, Piet ^c   Monsieurs, Pieter ^a   Michaux, Arlette ^a   De Meerleer, Gert ^c   Baatout, Sarah ^a,b   Thierens, Hubert ^b  

^a BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

H2AX; IMRT; Inflammatory response; Ionizing radiation; Low dose; Microarray; Prostate cancer; Radiotherapy

Indexed keywords

H2AFX PROTEIN, HUMAN; HISTONE;

CELL CYCLE; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INTENSITY MODULATED RADIATION THERAPY; MALE; PROSTATIC NEOPLASMS; RADIATION DOSE; RADIATION RESPONSE; SIGNAL TRANSDUCTION;

CELL CYCLE; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; HISTONES; HUMANS; INFLAMMATION; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; SIGNAL TRANSDUCTION;

EID: 84894414921     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2260     Document Type: Article

References (40)

1. Ahmad SS, Duke S, Jena R, Williams MV and Burnet NG: Advances in radiotherapy. BMJ 345: e7765, 2012.
2. Hall EJ and Wuu CS: Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56: 83-88, 2003.
3. Purdy JA: Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques. Health Phys 95: 666-676, 2008.
4. Hall EJ: Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65: 1-7, 2006.
5. Ruben JD, Davis S, Evans C, et al: The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys 70: 1530-1536, 2008.
6. Ost P, Speleers B, De Meerleer G, et al: Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study. Int J Radiat Oncol Biol Phys 79: 920-926, 2011.
7. Murray L, Henry A, Hoskin P, Siebert FA and Venselaar J; BRAPHYQS/PROBATE group of the GEC ESTRO: Second primary cancers after radiation for prostate cancer: a review of data from planning studies. Radiat Oncol 8: 172, 2013.
8. Wyrobek AJ, Manohar CF, Krishnan VV, et al: Low dose radiation response curves, networks and pathways in human lymphoblastoid cells exposed from 1 to 10 cGy of acute gamma radiation. Mutat Res 722: 119-130, 2011.
9. Yunis R, Albrecht H, Kalanetra KM, Wu S and Rocke DM: Genomic characterization of a three-dimensional skin model following exposure to ionizing radiation. J Radiat Res 53: 860-875, 2012.
10. Ray M, Yunis R, Chen X and Rocke DM: Comparison of low and high dose ionising radiation using topological analysis of gene coexpression networks. BMC Genomics 13: 190, 2012.
11. El-Saghire H, Thierens H, Monsieurs P, Michaux A, Vandevoorde C and Baatout S: Gene set enrichment analysis highlights different gene expression profiles in whole blood samples X-irradiated with low and high doses. Int J Radiat Biol 89: 628-638, 2013.
12. Pernot E, Hall J, Baatout S, et al: Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat Res 751: 258-286, 2012.
13. Subramanian A, Tamayo P, Mootha VK, et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550, 2005.
14. Werbrouck J, De Ruyck K, Beels L, et al: Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity. Oncol Rep 23: 571-578, 2010.
15. Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003.
16. Merico D, Isserlin R, Stueker O, Emili A and Bader GD: Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5: e13984, 2010.
17. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
18. Oakley JD, Taher MM, Hershey CM, Aggarwal PC, Estwani IB and Valerie K: Triggering of apoptosis is not sufficient to induce human immunodeficiency virus gene expression. IUBMB Life 55: 415-427, 2003.
19. Nowarski R, Wilner OI, Cheshin O, et al: APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. Blood 120: 366-375, 2012.
20. Zhu J, Ghosh A, Coyle EM, et al: Differential effects of phenethyl isothiocyanate and D,L-sulforaphane on TLR3 signaling. J Immunol 190: 4400-4407, 2013.
21. Amarante MK and Watanabe MA: Toll-like receptor 3: involvement with exogenous and endogenous RNA. Int Rev Immunol 29: 557-573, 2010.
22. Bauernfeind F, Ablasser A, Kim S, Bartok E and Hornung V: An unexpected role for RNA in the recognition of DNA by the innate immune system. RNA Biol 7: 151-157, 2010.
23. Vercammen E, Staal J and Beyaert R: Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 21: 13-25, 2008.
24. Chuang HC, Wang JM, Hsieh WC, Chang Y and Su IJ: Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders. Am J Pathol 173: 1397-1405, 2008.
25. Surjit M, Varshney B and Lal SK: The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-kappaB activity by blocking ubiquitination mediated proteasomal degradation of IkappaBalpha in human hepatoma cells. BMC Biochem 13: 7, 2012.
26. Hayden MS and Ghosh S: NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26: 203-234, 2012.
27. Liu SZ, Jin SZ, Liu XD and Sun YM: Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes. BMC Immunol 2: 8, 2001.
28. Shan YX, Jin SZ, Liu XD, Liu Y and Liu SZ: Ionizing radiation stimulates secretion of pro-inflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat Environ Biophys 46: 21-29, 2007.
29. Riley JL: PD-1 signaling in primary T cells. Immunol Rev 229: 114-125, 2009.
30. Kim SJ, Dix DJ, Thompson KE, et al: Effects of storage, RNA extraction, genechip type, and donor sex on gene expression profiling of human whole blood. Clin Chem 53: 1038-1045, 2007.
31. Liang X, So YH, Cui J, et al: The low-dose ionizing radiation stimulates cell proliferation via activation of the MAPK/ERK pathway in rat cultured mesenchymal stem cells. J Radiat Res 52: 380-386, 2011.
32. Sofia Vala I, Martins LR, Imaizumi N, et al: Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One 5: e11222, 2010.
33. Marcinkowska E, Superat K and Wiedlocha A: FGF-1 as a possible carrier for targeted drug delivery. Oncol Res 16: 27-34, 2006.
34. Shi M, Lin TH, Appell KC and Berg LJ: Cell cycle progression following naive T cell activation is independent of Jak3/common gamma-chain cytokine signals. J Immunol 183: 4493-4501, 2009.
35. Fernet M, Megnin-Chanet F, Hall J and Favaudon V: Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity. DNA Repair 9: 48-57, 2010.
36. Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P and Travis LB: Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol 30: 3734-3745, 2012.
37. Rashi-Elkeles S, Elkon R, Shavit S, et al: Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol Oncol 5: 336-348, 2011.
38. Aviv Y and Kirshenbaum LA: Novel phosphatase PHLPP-1 regulates mitochondrial Akt activity and cardiac cell survival. Circ Res 107: 448-450, 2010.
39. Alam MJ, Fatima N, Devi GR, Ravins and Singh RK: The enhancement of stability of p53 in MTBP induced p53-MDM2 regulatory network. Biosystems 110: 74-83, 2012.
40. Newhauser WD and Durante M: Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer 11: 438-448, 2011.